Article ; Online: Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operations.
JNCI cancer spectrum
2023 Volume 7, Issue 4
Abstract: Background: Oncology clinical trials are complex, and the COVID-19 pandemic caused major disruptions in 2020.: Methods: Using its networking and sharing of best practices, the Association of American Cancer Institutes, comprising 105 cancer centers, ... ...
| Abstract | Background: Oncology clinical trials are complex, and the COVID-19 pandemic caused major disruptions in 2020. Methods: Using its networking and sharing of best practices, the Association of American Cancer Institutes, comprising 105 cancer centers, solicited a longitudinal series of voluntary surveys from members to assess how clinical trial office operations were affected. The surveys showed that centers were able to keep oncology trials available to patients while maintaining safety. Data were collected regarding interventional clinical trial accruals for the calendar years 2019, 2020, and 2021. Results: Data demonstrated a sizeable decrease in interventional treatment trial accruals in both 2020 and 2021 compared with prepandemic figures in 2019. No cancer center reported an increase in interventional treatment trial accruals in 2020 compared with 2019, with most centers reporting a moderate decrease. In mid-2022, 15% of respondents reported an increasing trend, 31% reported no significant change, and 54% continued to report a decrease. Conclusions: The pandemic necessitated rapid adoption of trial operations, with the emergence of several best practices, including remote monitoring, remote consenting, electronic research charts, and work-from-home strategies for staff. The national infrastructure to conduct trials was significantly affected by the pandemic, with noteworthy resiliency, evidenced by improvements in efficiencies and patient-centered care delivery but with residual capacity challenges that will be evident for the foreseeable future. |
|---|---|
| MeSH term(s) | Humans ; United States/epidemiology ; COVID-19/epidemiology ; Pandemics ; Neoplasms/epidemiology ; Neoplasms/surgery ; Medical Oncology ; Research Design |
| Language | English |
| Publishing date | 2023-08-01 |
| Publishing country | England |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ISSN | 2515-5091 |
| ISSN (online) | 2515-5091 |
| DOI | 10.1093/jncics/pkad048 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.